| Date Filed | Type | Description |
| 02/12/2021 |
SC 13D/A
| Warburg Pincus Private Equity X, L.P. reports a 0% stake in Endurance International Group Holdings, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
SC 13D/A
| Warburg Pincus Private Equity X, L.P. reports a 35.9% stake in Endurance International Group Holdings, Inc. |
| 06/18/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/22/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/17/2017 |
SC 13D/A
| Warburg Pincus Private Equity X, L.P. reports a 6.5% stake in FINANCIAL ENGINES, INC. |
| 03/10/2017 |
SC 13D/A
| Financial Engines, Inc. reports a 6.6% stake in FINANCIAL ENGINES, INC. |
| 03/07/2017 |
SC 13D/A
| Financial Engines, Inc. reports a 13.2% stake in FINANCIAL ENGINES, INC. |
| 09/27/2016 |
SC 13D
| Warburg Pincus Private Equity X, L.P. reports a 37.1% stake in Endurance International Group Holdings, Inc. |
| 06/05/2013 |
SC 13D/A
| Primerica, Inc. reports a 0% stake in PRIMERICA, INC. |
| 05/29/2013 |
SC 13D/A
| Primerica, Inc. reports a 10.9% stake in PRIMERICA, INC. |
| 05/09/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 03/20/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 02/15/2013 |
SC 13D/A
| Primerica, Inc. reports a 10.9% stake in PRIMERICA, INC. |
| 02/12/2013 |
SC 13D/A
| Primerica, Inc. reports a 15% stake in PRIMERICA, INC. |
| 11/28/2012 |
SC 13D/A
| Primerica, Inc. reports a 15% stake in PRIMERICA, INC. |
| 11/21/2012 |
SC 13D/A
| Primerica, Inc. reports a 20.6% stake in PRIMERICA, INC. |
| 11/15/2012 |
SC 13D/A
| Warburg Pincus Private Equity X, L.P. reports a 92.4% stake in Talon Therapeutics, Inc. |
| 10/04/2012 |
SC 13D/A
| Primerica, Inc. reports a 23.3% stake in PRIMERICA, INC. |
| 08/17/2012 |
SC 13D/A
| Warburg Pincus Private Equity X, L.P. reports a 92.3% stake in Talon Therapeutics, Inc. |
| 07/03/2012 |
SC 13D/A
| Warburg Pincus Private Equity X, L.P. reports a 92.4% stake in Talon Therapeutics, Inc. |
| 06/05/2012 |
SC 13D/A
| Warburg Pincus Private Equity X, L.P. reports a 30.8% stake in China Biologic Products, Inc. |
| 04/27/2012 |
SC 13D/A
| Primerica, Inc. reports a 23.2% stake in PRIMERICA, INC. |
| 04/18/2012 |
SC 13D/A
| Primerica, Inc. reports a 29.6% stake in PRIMERICA, INC. |
| 12/21/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 12/19/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 11/17/2011 |
SC 13D/A
| Primerica, Inc. reports a 29.7% stake in PRIMERICA, INC. |
| 09/19/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 05/26/2011 |
SC 13D/A
| China Biologic Products, Inc. reports a 21.4% stake in China Biologic Products, Inc. |
| 04/21/2011 |
SC 13D/A
| Primerica, Inc. reports a 26.4% stake in PRIMERICA, INC. |
| 02/03/2011 |
SC 13D/A
| Talon Therapeutics, Inc. reports a 71.1% stake in Talon Therapeutics, Inc. |
| 01/11/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 12/29/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 11/16/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
|